Search Within

Chau Dang

Formats
  1. Journal Article (132)
  2. Meeting Abstract (122)
  3. Guidelines (8)
  4. Book Section (4)
  5. Review (3)
  6. Book Whole (1)
  7. Editorial (1)
  8. Miscellaneous (1)
  9. Research Letter (1)
Groups
  1. Breast Medicine Service (273)
  2. Department of Medicine (273)
  3. Solid Tumor Oncology Division (273)
  4. Survivorship Research (273)
  5. Population Sciences Research Program (119)
  6. Epidemiology and Biostatistics (93)

More Groups

People
  1. Clifford Hudis (111)
  2. Larry Norton (76)
  3. Richard Steingart (49)
  4. Anthony Yu (46)
  5. Shanu Modi (42)
  6. Sujata Patil (41)

More People

Years
  1. 2025 (4)
  2. 2024 (12)
  3. 2023 (15)
  4. 2022 (18)
  5. 2021 (12)
  6. 2020 (20)

More Years

Publications
  1. Journal of Clinical Oncology (68)
  2. Cancer Research (42)
  3. Breast Cancer Research and Treatment (23)
  4. Annals of Oncology (10)
  5. Clinical Breast Cancer (7)
  6. Clinical Cancer Research (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (70)
  2. American Association for Cancer Research (50)
  3. Springer (33)
  4. Oxford University Press (22)
  5. Elsevier Inc. (16)
  6. American Medical Association (11)

More Publishers

Results (273)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Invasive disease free survival and brain metastasis rates in patients treated with neoadjuvant chemotherapy with trastuzumab and pertuzumab
    Meeting Abstract

    Chew, S.; Ferraro, E.; Chen, Y.; Barrio, A. V.; Kelly, D. W.; Modi, S.; Seidman, A. D.; Wen, H. Y.; Brogi, E.; Robson, M. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Evolving perspectives on the treatment of HR+/HER2+ metastatic breast cancer
    Review

    Pegram, M.; Pietras, R.; Dang, C. T.; Murthy, R.; Bachelot, T.; Janni, W.; Sharma, P.; Hamilton, E.; Saura, C.
    Therapeutic Advances in Medical Oncology (2023)

    Fulltext@MSK | Save
  • NCCN GuidelinesĀ® Insights: Breast cancer, version 4.2023
    Guidelines

    Gradishar, W. J.; Moran, M. S.; Abraham, J.; Abramson, V.; Aft, R.; Agnese, D.; Allison, K. H.; Anderson, B.; Burstein, H. J.; Chew, H.; more...
    Journal of the National Comprehensive Cancer Network (2023)

    Fulltext@MSK | Save
  • Real-world first-line use of pertuzumab with different taxanes for human epidermal growth factor receptor 2 positive metastatic breast cancer: A comparative effectiveness study using US electronic health records
    Journal Article

    Polito, L.; Shim, J.; Hurvitz, S. A.; Dang, C. T.; Knott, A.; Du Toit, Y.; Restuccia, E.; Sanglier, T.; Swain, S. M.
    JCO Oncology Practice (2023)

    Fulltext@MSK | Save
  • Association of circulating cardiomyocyte cell-free DNA with cancer therapy-related cardiac dysfunction in patients undergoing treatment for ERBB2-positive breast cancer
    Journal Article

    Yu, A. F.; Moore, Z. R.; Moskowitz, C. S.; Liu, J. E.; Dang, C. T.; Ramanathan, L.; Oeffinger, K. C.; Steingart, R. M.; Schmitt, A. M.
    JAMA Cardiology (2023)

    Fulltext@MSK | Save
  • Cytochrome P450 oxidoreductase (POR) associated with severe paclitaxel-induced peripheral neuropathy in patients of European ancestry from ECOG-ACRIN E5103
    Journal Article

    Shen, F.; Jiang, G.; Philips, S.; Gardner, L.; Xue, G.; Cantor, E.; Ly, R. C.; Osei, W.; Wu, X.; Dang, C.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Rationale and design of a cardiac safety study for reduced cardiotoxicity surveillance during HER2-targeted therapy
    Journal Article

    Yu, A. F.; Dang, C. T.; Jorgensen, J.; Moskowitz, C. S.; DeFusco, P.; Oligino, E.; Oeffinger, K. C.; Liu, J. E.; Steingart, R. M.
    Cardio-Oncology (2023)

    Fulltext@MSK | Save
  • Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: Final 10-year analysis of the open-label, single-arm, phase 2 APT trial
    Journal Article

    Tolaney, S. M.; Tarantino, P.; Graham, N.; Tayob, N.; PareĢ€, L.; Villacampa, G.; Dang, C. T.; Yardley, D. A.; Moy, B.; Marcom, P. K.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • Cardiac safety study for reduced cardiotoxicity surveillance in patients with HER2-positive breast cancer
    Meeting Abstract

    Yu, A. F.; Dang, C.; Jorgensen, J.; Liu, J. E.; Moskowitz, C.; Oligino, E. J.; Oeffinger, K. C.; Steingart, R. M.
    Journal of the American College of Cardiology (2023)

    Fulltext@MSK | Save
  • Innate immune signaling drives late cardiac toxicity following DNA-damaging cancer therapies
    Journal Article

    Shamseddine, A.; Patel, S. H.; Chavez, V.; Moore, Z. R.; Adnan, M.; Di Bona, M.; Li, J.; Dang, C. T.; Ramanathan, L. V.; Oeffinger, K. C.; more...
    Journal of Experimental Medicine (2023)

    Fulltext@MSK | Save